Oncolytics Biotech Inc T.ONC

Pelareorep synergizes with azacitidine

[askretka]

The trial being stopped, ENHANCE, was studying the use ofs magrolimab plus a type of chemotherapy called azacitidine (Vidaza) in patients with higher-risk myelodysplastic syndromes, or MDS.

I always found it interesting that when magrolimab study was stopped by FDA temporary the first time 

We had a press release around the same time that said Pelareorep was synergistic in leukemia with azacitidine but we didn't get noticed really. 



https://www.newswire.ca/news-releases/oncolytics-biotech-r-announces-the-presentation-of-preclinical-data-demonstrating-the-synergistic-anti-leukemic-effects-of-pelareorep-combined-with-azacitidine-at-the-2021-american-society-of-hematology-annual-meeting-889202448.html

[jimsenior]

I noticed Immugene was mentioned on another site. Perhaps it is of interest to note that Dr. Laeufle who was closely involved with the GOBLET design, left ONC/Y to work for a time at Immugene. It is not too much of a stretch to imagine that she was aiding and advising pharma on oncolytic viruses. That is just idle speculation on my part. The excellent design of GOBLET is not. We shall patiently